The following videos provide domain-specific training for all site personnel. Please let your regional management team know if you have any questions after viewing the content.
Find information on specific consent aspects using the times specified below:
0:00 - Consent Overview & Tips
1:20 - Consent for the SNAP Platform
2:55 - Consent for the SNAP Registry
3:40 - Surrogate Consent & Regained Capacity
4:20 - Pregnant Patient Consent
5:20 - Paediatric Patient Consent & Assent
6:10 - Assent for Domains with Delayed Reveals
7:00 - The Simplified, Layered Consent Model
The primary objective for this domain is to determine if adjunctive therapy (clindamycin) improves outcomes of patients with SAB.
The primary objective for this domain is to determine the best backbone antibiotic to improve outcomes of patients with SAB.
The primary objective for this domain is to determine the best backbone antibiotic to improve outcomes of patients with SAB.
The primary objective for this domain is to determine if early oral switch is non-inferior to continued intravenous (IV) treatment for PSSA, MSSA and MRSA bacteraemia.
Click to download PDF of the master trial protocols and appendices.
Please contact your regional coordinating team for local versions of these documents.
Professor Joshua S Davis PhD, FRACP, MBBS (Hons), DTM&H, Grad Cert Pop Health. Infectious Diseases Physician and NHMRC Career Development Fellow at the University of Newcastle and the Menzies School of Health Research.
Professor Steven YC Tong PhD, FRACP, MBBS (Hons), Grad Dip Epidemiol Biostats, Infectious Diseases Physician with the Victorian Infectious Diseases Service.
